Laura E. Lantry

Myoblast Transfer in the Treatment of Duchenne's Muscular Dystrophy

Jerry R. Mendell, John T. Kissel, Anthony A. Amato et al. · New England Journal of Medicine · 1995 · 522 citations · Full text

Medicine, Genetics, Molecular Genetics +13

177Lu-AMBA: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer.

Laura E. Lantry, Enrico Cappelletti, Mary Ellen Maddalena et al. · PubMed · 2006 · 175 citations

Medicine, Pharmacokinetics, Pharmacology +17

A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin.

Zhongqiu Zhang, Qing Liu, Laura E. Lantry et al. · PubMed · 2000 · 101 citations

Medicine, Genetics, Oncology +17

¹⁷⁷Lu-AMBA Biodistribution, Radiotherapeutic Efficacy, Imaging, and Autoradiography in Prostate Cancer Models with Low GRP-R Expression

Mary Ellen Maddalena, Jaclyn Fox, Jianqing Chen et al. · Journal of Nuclear Medicine · 2009 · 84 citations · Full text

Medicine, Oncology, Pharmacology +17

5-Aza-2'-deoxycytidine is chemopreventive in a 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone-induced primary mouse lung tumor model

Laura E. Lantry · Carcinogenesis · 1999 · 66 citations · Full text

Medicine, Cancer Biology, Oncology +17